How Transformative Is This Licensing Deal for BeiGene?
This partnership should be fairly transformative for BeiGene, seeing as it can start making some actual money.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 164
Athenex Wins Big on Chinese Cancer Drug
Athenex led biotech stocks higher on Wednesday after its Chinese subsidiary submitted an Investigational New Drug application to the China Food and Drug Administration.
Array BioPharma’s New FDA Submissions Enough to Excite Investors?
Array BioPharma has announced the submission to the FDA of two New Drug Applications to support the use of the combination of binimetinib and encorafenib for the treatment of patients with melanoma.
Top Stocks to Look For on July’s FDA Calendar
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of July and added some color.
Report Ties Drop in Childhood Lead Exposure With Crime Decrease
A drop in the exposure to lead among children in their preschool years reduces antisocial behavior and may be a factor behind the decline in crime over the past few decades.
Study Shows Alaskans Spend Most on Drugs per Day
A new report details the extent of Americans’ drug consumption, which are the narcotics of choice, which states' residents spend the most to get the drugs and what some people are willing to do…
Bluebird Bio Gears Up for $350 Million Offering
Bluebird Bio shares have made a steady gain over the course of the year and now the firm is looking to cash in on this growth.
Analyst Predicts Major Short Squeeze in 4 Biotech Stocks to Buy
Many on Wall Street feel that some of the more speculative institutional tech money may be rotating into the biotechs, and with good reason.
Major Biotech Short Interest Surges
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Short Sellers Run for Cover From Major Pharma
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks shrank.
Agio Pharma Sinks on Midstage Trial
Agio Pharmaceuticals saw its shares sink on Monday after the firm announced results from its midstage trial for the treatment of relapsed or refractory acute myeloid leukemia.
Cara Therapeutics Wins Big on FDA Breakthrough
Cara Therapeutics saw its shares rise on Friday after the company said that the FDA granted a Breakthrough Therapy designation on its uremic pruritus treatment.
Jefferies Sees 6 Biotechs as Undervalued With Massive Upside
Jefferies has picked out a few companies in the biotech industry that stand to win big over the coming year.
Clovis Looks to Cash in on Secondary Offering
Clovis Oncology saw its shares make a handy gain in Wednesday’s session after the company priced its secondary offering.
Does Eiger BioPharmaceuticals Really Have 400% Upside?
Why do so many analysts on Wall Street have such massive upside targets for a speculative stock such as Eiger BioPharmaceuticals.